What is the most likely cause of death in a female cancer patient who was hospitalized for seven days, underwent cystoscopy with intraoperative bleeding requiring transfusion for hemoglobin 7.0 g/dL, then developed postoperative dyspnea, sinus tachycardia on electrocardiogram, and cardiac arrest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Most Likely Cause of Death: Pulmonary Embolism (PE)

The most likely cause of death in this cancer patient who developed postoperative dyspnea, sinus tachycardia, and cardiac arrest following cystoscopy with bleeding is pulmonary embolism (PE), given the constellation of multiple high-risk factors for venous thromboembolism (VTE).

Clinical Reasoning

This patient had a perfect storm of VTE risk factors that makes PE the leading cause of death:

Cancer-Associated VTE Risk

  • VTE is the second leading cause of death in cancer patients after disease progression 1
  • Cancer patients have a 4.1-fold increased risk of thrombosis, and VTE is responsible for 46% of deaths within 30 days after surgery 2
  • The risk is highest in the initial period after diagnosis and during active treatment 2
  • 40% of VTE events occur 21 days after surgery, and up to one-fourth of symptomatic thromboembolic events occur after discharge 2

Specific Risk Factors Present in This Case

Patient-related factors:

  • Female gender
  • Cancer diagnosis
  • 7-day hospitalization (prolonged immobilization) 3
  • Severe anemia (Hb 7.0 g/dL) - hemoglobin <10 g/dL is predictive of VTE 3

Surgery-related factors:

  • Underwent invasive urologic procedure (cystoscopy)
  • Intraoperative bleeding requiring transfusion
  • Postoperative period (highest VTE risk) 2

Treatment-related factors:

  • Blood transfusion itself increases VTE risk 3

Classic Presentation of Fatal PE

The clinical sequence is textbook for massive PE:

  1. Dyspnea - the most typical early symptom of serious complications, including PE 4
  2. Sinus tachycardia - cardiovascular response to acute PE
  3. Sudden cardiac arrest - consistent with massive PE causing acute right heart failure

Why Not Other Causes?

Transfusion-Associated Circulatory Overload (TACO)

While TACO is now the most common cause of transfusion-related mortality 4, it is less likely here because:

  • TACO typically occurs during or up to 12 hours after transfusion 4
  • This patient was transfused for Hb 7.0 g/dL and developed symptoms postoperatively (timing suggests days later, not immediately)
  • TACO presents with hypertension and pulmonary edema; this patient had tachycardia leading to arrest, more consistent with obstructive shock from PE

Transfusion Reaction

  • Hemolytic and allergic reactions typically occur within 24 hours 4
  • The delayed postoperative presentation makes this less likely
  • No mention of fever, hemoglobinuria, or urticaria

Hemorrhagic Shock

  • Patient was already transfused for the intraoperative bleeding
  • Hemorrhagic shock would present differently (hypotension, ongoing bleeding signs)
  • The dyspnea and sudden arrest pattern fits PE better

Critical Pitfalls in This Case

The major failure was likely inadequate VTE prophylaxis:

  • All hospitalized cancer patients with acute medical conditions or reduced mobility should receive pharmacologic thromboprophylaxis throughout hospitalization 5
  • Patients undergoing procedures lasting >30 minutes should receive prophylaxis starting preoperatively and continuing at least 7-10 days postoperatively 2
  • Prolonged prophylaxis up to 4 weeks should be considered in cancer surgery patients with high-risk features 2

This patient should have received:

  • Preoperative VTE risk assessment 5
  • Pharmacologic prophylaxis with LMWH or low-dose UFH unless contraindicated 2, 5
  • Mechanical prophylaxis (pneumatic compression) as adjunct, especially given bleeding risk 2
  • Extended prophylaxis given cancer diagnosis and hospitalization 2

Evidence Strength

The evidence supporting PE as the cause is strong:

  • Multiple high-quality guidelines from ASCO 2, 5 and NCCN 3 consistently identify VTE as a leading cause of perioperative death in cancer patients
  • The 2022 ITAC guidelines 1 provide the most recent comprehensive evidence on cancer-associated thrombosis
  • The clinical presentation (dyspnea → tachycardia → arrest) is the classic progression of massive PE

The combination of cancer, surgery, anemia, transfusion, and inadequate prophylaxis created a lethal VTE risk that manifested as fatal pulmonary embolism 3, 2, 3, 2, 1, 5.

References

3
Guideline

venous thromboembolic disease.

Journal of the National Comprehensive Cancer Network : JNCCN, 2013

Related Questions

In a 43‑year‑old woman with iron‑deficiency anemia who has started oral iron therapy, when should the iron studies and complete blood count (CBC) be repeated?
How should persistent anemia four months after chemotherapy be evaluated and managed?
A patient with chronic anemia and a hemoglobin of 7 g/dL should be sent to the hospital for a blood transfusion?
In a 65‑year‑old woman with a large non‑obstructing sigmoid adenocarcinoma causing severe anemia (hemoglobin 5.1 g/dL) and an incidental asymptomatic eccentric abdominal aortic thrombus, what are the appropriate next management steps for both the cancer and the thrombus?
Would a patient with a hemoglobin level of 6.9 g/dL survive without medical intervention?
As the primary care physician, how should I manage a female patient on bupropion (Wellbutrin) who for the past week has experienced increased fatigue, emotional lability, panic symptoms, tension‑type headaches, and diarrhea?
What protocol should a skilled nursing facility or long‑term care facility follow for patients receiving cough‑assist (mechanical insufflation‑exsufflation) and high‑frequency chest wall oscillation vest therapy?
What is the recommended acute management for methamphetamine intoxication and the long‑term treatment options for methamphetamine use disorder?
When is it appropriate to order an anti‑streptolysin O (ASO) titer to screen for recent streptococcal infection?
In a facility caring for patients with chronic tracheostomy and non‑weanable mechanical ventilation, is it appropriate to require that all residents receive mechanical insufflation‑exsufflation (cough‑assist) and high‑frequency chest wall oscillation vest therapy three times daily for 90 days with indefinite renewal, regardless of individual indications?
Does smoking increase the risk of ear infections?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.